Virtu Financial’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,895
| Closed | -$222K | – | 1445 |
|
|
2025
Q1 | $222K | Sell |
25,895
-64,139
| -71% | -$550K | 0.01% | 767 |
|
|
2024
Q4 | $967K | Buy |
+90,034
| New | +$967K | 0.05% | 309 |
|
|
2024
Q2 | – | Sell |
-40,612
| Closed | -$207K | – | 1302 |
|
|
2024
Q1 | $207K | Buy |
40,612
+18,954
| +88% | +$96.6K | 0.02% | 772 |
|
|
2023
Q4 | $202K | Buy |
+21,658
| New | +$202K | 0.02% | 822 |
|
|
2023
Q3 | – | Sell |
-11,507
| Closed | -$94K | – | 1294 |
|
|
2023
Q2 | $94K | Sell |
11,507
-56,858
| -83% | -$464K | 0.01% | 1052 |
|
|
2023
Q1 | $586K | Buy |
68,365
+38,751
| +131% | +$332K | 0.06% | 301 |
|
|
2022
Q4 | $274K | Buy |
+29,614
| New | +$274K | 0.04% | 532 |
|
|
2022
Q1 | – | Sell |
-15,523
| Closed | -$269K | – | 1490 |
|
|
2021
Q4 | $269K | Buy |
+15,523
| New | +$269K | 0.03% | 686 |
|
|
2021
Q3 | – | Sell |
-81,011
| Closed | -$1.85M | – | 1497 |
|
|
2021
Q2 | $1.85M | Buy |
+81,011
| New | +$1.85M | 0.18% | 84 |
|
|
2021
Q1 | – | Sell |
-15,050
| Closed | -$81K | – | 1588 |
|
|
2020
Q4 | $81K | Sell |
15,050
-15,696
| -51% | -$84.5K | 0.01% | 1114 |
|
|
2020
Q3 | $140K | Buy |
30,746
+17,843
| +138% | +$81.2K | 0.02% | 661 |
|
|
2020
Q2 | $63K | Buy |
+12,903
| New | +$63K | 0.01% | 974 |
|
|
2019
Q4 | $88K | Sell |
33,935
-16,504
| -33% | -$42.8K | 0.01% | 1105 |
|
|
2019
Q3 | $159K | Buy |
+50,439
| New | +$159K | 0.01% | 1015 |
|
|
2019
Q2 | – | Sell |
-49,580
| Closed | -$152K | – | 1436 |
|
|
2019
Q1 | $152K | Buy |
+49,580
| New | +$152K | 0.01% | 1052 |
|
|
2017
Q4 | – | Sell |
-24,671
| Closed | -$102K | – | 2351 |
|
|
2017
Q3 | $102K | Buy |
+24,671
| New | +$102K | 0.01% | 2072 |
|